A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034

NCT01813812 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

492

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Gastritis
Chronic Gastritis

Interventions

DRUG: DA-6034
DRUG: Rebamipide 300mg

Sponsor

Dong-A Pharmaceutical Co., Ltd.